Inspection Record

Groupe Marcelle Inc. — Health Canada Inspection Findings

Health CanadaInspected 2021-05-17 11 findingsTraining and personnelEquipment and facilityDeviation, CAPA, and investigationLaboratory and QC controlsComputer system validationComplaint and recall handlingRegulatory reporting and change controlOther quality systemStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Training and personnel

The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.

2Equipment and facility

The maintenance of records was inadequate.

3Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate. The evaluation was inadequate for cases where there was a deviation from the norm and/or where products were on the borderline of the acceptable range.

4Laboratory and QC controls

The validation and/or the documentation of test methods was inadequate.

5Computer system validation

The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

6Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

7Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

8Other quality system

The master production documents were inadequate.

9Computer system validation

The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

10Stability and storage

The ongoing stability program for a drug was inadequate.

11Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-05-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Groupe Marcelle Inc. findings history — including this company's other documents Health Canada documents, 2021 Go to Findings search